Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ·Healthcare·Biotechnology
$3.94
+2.34%
Mkt Cap $263.69M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$13.00
Range $13.00 – $13.00
Implied Upside
+229.9%
Consensus $13.00 vs current $3.94